SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) was awarded 510(k) clearance from the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) for the Celution™ Cell Concentration System as a cell saver device. The system is cleared for the collection, concentration, washing and re-infusion of a patient’s own cells for applications that may include, but are not limited to, cardiovascular, plastic and reconstructive, orthopedic, vascular, and urological surgeries and procedures.
